Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Landos Biopharma Inc (NQ: LABP )

22.33 -0.03 (-0.13%)
Streaming Delayed Price Updated: 3:52 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,749
Open 22.13
Bid (Size) 21.88 (1)
Ask (Size) 22.48 (3)
Prev. Close 22.36
Today's Range 22.13 - 22.38
52wk Range 2.500 - 22.84
Shares Outstanding 31,168,449
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LABP Stock Earnings: Landos Biopharma Misses EPS for Q1 2024
LABP stock results show that Landos Biopharma missed analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook
AbbVie impresses with Q1 results: EPS beats at $2.31 (-6.1% Y/Y), net revenue exceeds at $12.31 billion (+0.7%). Notable: Immunology sales, Humira vs. biosimilars, oncology gains. 
Via Benzinga

Performance

YTD
+416.90%
+416.90%
1 Month
+3.86%
+3.86%
3 Month
+331.08%
+331.08%
6 Month
+483.03%
+483.03%
1 Year
+646.82%
+646.82%

More News

Read More
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN)
From Brodsky & Smith LLC
Via GlobeNewswire
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABP
From Kahn Swick & Foti, LLC
Via Business Wire
Recap: Landos Biopharma Q4 Earnings
Via Benzinga
Nasdaq Turns Higher; Akanda Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Landos Biopharma: Q3 Earnings Insights
Via Benzinga
Recap: Landos Biopharma Q1 Earnings
Via Benzinga
Is the Stock Market Closed on Good Friday 2024?
Via InvestorPlace
Why Is Landos Biopharma (LABP) Stock Up 168% Today?
Via InvestorPlace
Crude Oil Moves Higher; US New Home Sales Fall In February
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
LABP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Landos Biopharma, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)
From Brodsky & Smith LLC
Via GlobeNewswire
US Stocks Down; Chicago Fed National Activity Index Rises In February
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
LABP Stock Earnings: Landos Biopharma Misses EPS for Q4 2023
Via InvestorPlace
Landos Biopharma - Investor Like It Better Than Analysts
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.